A guideline for economic evaluations of vaccines and immunization programs in China
- PMID: 36287462
- PMCID: PMC9746533
- DOI: 10.1080/21645515.2022.2132802
A guideline for economic evaluations of vaccines and immunization programs in China
Abstract
This study aimed to develop a consensus framework for economic evaluations of vaccines as a national guideline in China. Some unique and important aspects were particularly emphasized. Nineteen Chinese experts in the field of health economics and immunization decision-making were nominated to select and discuss relevant aspects of vaccine economic evaluations in China. A workshop attended by external experts was held to summarize unique and important aspects and formulate consensus recommendations. There were ten unique and/or important aspects identified for economic evaluations of vaccines in China, including study perspectives, comparator strategies, analysis types, model choices, costing approaches, utility measures, discounting, uncertainty, equity, and evaluation purposes. Background information and expert recommendations were provided for each aspect. Economic evaluations of vaccines should play an important role in China's immunization policy-making. This guideline can help improve the quality of economic evaluations as a good practice consensus.
Keywords: China; Vaccine; economic evaluation; guide.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Similar articles
-
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.Pharmacoeconomics. 2016 Mar;34(3):227-44. doi: 10.1007/s40273-015-0335-2. Pharmacoeconomics. 2016. PMID: 26477039 Free PMC article.
-
WHO-led consensus statement on vaccine delivery costing: process, methods, and findings.BMC Med. 2022 Mar 8;20(1):88. doi: 10.1186/s12916-022-02278-4. BMC Med. 2022. PMID: 35255920 Free PMC article. Review.
-
Improving Innovation and Access to Combination Vaccines for Childhood Immunization in China.Int J Environ Res Public Health. 2022 Nov 23;19(23):15557. doi: 10.3390/ijerph192315557. Int J Environ Res Public Health. 2022. PMID: 36497631 Free PMC article.
-
Incorporation of health economic evaluation into immunization policy-making in Canada: Barriers and facilitators.Vaccine. 2020 Mar 4;38(11):2512-2518. doi: 10.1016/j.vaccine.2020.01.092. Epub 2020 Feb 11. Vaccine. 2020. PMID: 32057578
-
Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines.Pediatr Infect Dis J. 2004 Jan;23(1):32-7. doi: 10.1097/01.inf.0000105104.39284.a3. Pediatr Infect Dis J. 2004. PMID: 14743043
Cited by
-
Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review.Hum Vaccin Immunother. 2024 Dec 31;20(1):2313860. doi: 10.1080/21645515.2024.2313860. Epub 2024 Feb 15. Hum Vaccin Immunother. 2024. PMID: 38359815 Free PMC article. Review.
-
Adverse Events Following Haemophilus influenzae Type b (Hib) Monovalent Vaccines in Zhejiang Province, China, from 2017 to 2023.Vaccines (Basel). 2025 Mar 25;13(4):349. doi: 10.3390/vaccines13040349. Vaccines (Basel). 2025. PMID: 40333242 Free PMC article.
-
Service delivery costs of vaccination at health facilities in Guangzhou, China.Hum Vaccin Immunother. 2025 Dec;21(1):2545031. doi: 10.1080/21645515.2025.2545031. Epub 2025 Aug 18. Hum Vaccin Immunother. 2025. PMID: 40820686 Free PMC article.
-
Vaccine pricing strategies in China.BMJ Glob Health. 2023 Jul;8(7):e011405. doi: 10.1136/bmjgh-2022-011405. BMJ Glob Health. 2023. PMID: 37402511 Free PMC article. No abstract available.
-
Evaluating Free PPV23 Vaccination for the Elderly in Nanning, China: A Cost-Effectiveness Analysis.Vaccines (Basel). 2025 Jul 18;13(7):763. doi: 10.3390/vaccines13070763. Vaccines (Basel). 2025. PMID: 40733740 Free PMC article.
References
-
- Chinese Center for Disease Control and Prevention . Achievements of 40 years’ national immunization programs in China. 2018.
-
- Yu W, Lee LA, Liu Y, Scherpbier RW, Wen N, Zhang G, Zhu X, Ning G, Wang F, Li Y, et al. Vaccine-preventable disease control in the People’s Republic of China: 1949-2016. Vaccine. 2018. Dec 18;36(52):1–9. doi:10.1016/j.vaccine.2018.10.005. Epub 2018 Nov 26. PMID: 30497834; PMCID: PMC7115483. - DOI - PMC - PubMed
-
- Chinese Center for Disease Control and Prevention, Childhood Immunization Schedule for National Immunization Program Vaccines . Version 2021. [accessed 2022 July 23]. https://www.chinacdc.cn/nip/kyjz/mycxbjsm/mycxb/
-
- Lai X, Fang H.. Immunization programs in the USA, the UK, Germany, and Japan, and their implication for vaccine financing. Natl Med J China. 2020;100:85–88.
-
- World Health Organization . Principles and considerations for adding a vaccine to a national immunization program: from decision to implementation and monitoring. Geneva. 2014.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical